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Background: We examined linkage to care for patients with sexually transmitted infection who were diagnosed HIV-
positive via the provider-initiated HIV testing and counselling (PITC) approach, as compared to the voluntary counselling
and testing (VCT) approach, as little is known about the impact of expanded testing strategies on linkage to care.
Methods: In a controlled trial on PITC (Cape Town, 2007), we compared HIV follow-up care for a nested cohort of 930
HIV-positive patients. We cross-referenced HIV testing and laboratory records to determine access to CD4 and viral load
testing as primary outcomes. Secondary outcomes were HIV immune status and time taken to be linked to HIV care.
Logistic regression was performed to analyse the difference between arms.
Results: There was no difference in the main outcomes of patients with a record of CD4 testing (69.9% in the
intervention, 65.2% in control sites, OR 0.82 (CI: 0.44-1.51; p = 0.526) and viral load testing (14.9% intervention versus 10.9%
control arm; OR 0.69 (CI: 0.42-1.12; p = 0.131). In the intervention arm, ART-eligible patients (based on low CD4 test result),
accessed viral load testing approximately 2.5 months sooner than those in the control arm (214 days vs. 288 days, HR:
0.417, 95% CI: 0.221-0.784; p = 0.007).
Conclusion: The PITC intervention did not improve linkage to CD4 testing, but shortened the time to viral load testing
for ART-eligible patients. Major gaps found in follow-up care across both arms, indicate the need for more effective
linkage-to-HIV care strategies.
Trial registration: Current Controlled Trials ISRCTN93692532
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The ultimate aim of approaches to expand HIV testing is
to improve access to prevention, care and treatment ser-
vices, through early detection of HIV [1]. The secondary
prevention benefits of early detection and antiretroviral
treatment (ART) has been demonstrated by studies using
the ‘test and treat’ strategy - aimed at reducing HIV* Correspondence: natalie.leon@mrc.ac.za
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Provider-initiated HIV testing and counselling (PITC) is
an approach to expand HIV testing through integrating
the routine offer of HIV testing into standard care in med-
ical settings [1,4]. The focus of PITC studies has been
largely on feasibility, acceptability and increasing test up-
take and there have been positive findings in all three
areas [5-8]. Questions remain about the ethics of increas-
ing the number of patients who receive a HIV diagnosis
when many may not be able to access the survival gains
associated with ART, especially in low-resource settings
[9-13]. Despite the aim of improved access to care and thed. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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linkage to care, as compared to other approaches such as
voluntary counselling and testing (VCT).
Claims that PITC may be able to increase access to
earlier diagnosis and care compared to other testing
approaches (through, for instance, integrating HIV test-
ing into standard clinical care), are still unsubstantiated
[10,13]. The little evidence available does not appear to
bear out the concerns about reduced access for patients
diagnosed HIV-positive via the PITC approach. A rando-
mised controlled study of PITC for TB patients in South
Africa found no difference in linkage to care compared
to VCT with respect to referrals for HIV medical care or
prescriptions for cotrimoxazole prophylaxis [14]. Simi-
larly, a review of routine data for PMTCT patients after
the introduction of routine HIV screening in Botswana
in 2004, found that significantly more women knew their
HIV status at delivery, but that there was no difference
to the proportions who had been initiated on antiretro-
viral therapy [15]. Few studies have pointed to a positive
impact of PITC on linkage to care as compared to stand-
ard opt-in approaches. A Zimbabwe study in 2005 com-
pared mother-to-child transmission (PMTCT) service
indicators during a 6 month routine HIV testing period
with the prior opt-in testing period and found signifi-
cantly more women in the routine testing period re-
ceived their test results and were post-test counselled
and more mother-infant pairs were seen at their 6 week
follow-up visits [16]. Stronger evidence emerged from a
South African retrospective review that found a statisti-
cally significant temporal association between the intro-
duction of PITC for patients with TB in 2005, and
subsequent increased referrals to ART (from 16% in the
period 2002–2005 to 34.7% in 2007–2008) [17].
Evidence on linkage to care in relation to different HIV
testing strategies is often variable and difficult to interpret
as definitions of linkage to care are not uniform across
studies [18]. The variety of HIV testing strategies, patient
populations and health system contexts that are studied
also make it difficult to compare findings on linkage to
care. For instance, two South African retrospective studies
had contradictory findings about whether patients who
accessed routine, provider-initiated HIV testing (as op-
posed to self-initiated testing), had better linkage to care –
and it was not clear to what extend the testing strategies
in the two studies are comparable. The one study exam-
ined the PHC records of a random sample of HIV positive
patients living in one geographical community in Cape
Town, selecting from antenatal, STI and TB patients as
well as those who self-initiated VCT. The authors sug-
gested that patients who tested via routine screening (such
as for antenatal patients) had better linkage to HIV care
than those who self-initiated [19]. The other study exam-
ined linkage to care for an out-patient cohort of HIVpositive patients (excluding antenatal patients) at a semi-
private and a state-aided hospital and suggested that those
who self-initiated HIV testing may be more motivated to
seek follow-up care than those who were medically re-
ferred [20]. The variation in PITC strategies used (often
with insufficient description of the intervention), makes it
harder to interpret findings and compare results across
PITC studies. There may not be one single answer to how
PITC impacts on linkage to care and part of the variability
may be due to the contextual variables mentioned above.
The cascade of care for HIV positive patients comprises
various stages. The first is from HIV testing to staging for
HIV immune status through CD4 testing and clinical
examination (often referred to as ‘linkage to care’), next is
the period between the staging and becoming ART-eli-
gible, followed by initiation on ART, and finally the stage
from ART initiation to retention in care [2,18]. In this
study, the focus is on the first two stages of care, that is,
the stage of linkage to CD4 testing (and determining ART
eligibility) and the stage of linkage to viral load testing (the
latter as a proxy for initiation on ART).
A systematic review of linkage to care between HIV test-
ing and ART initiation in Sub Saharan Africa showed that
by the end of 2009, only about a third (33%) of those HIV
positive patients who needed ART (based on their low
CD4 count, also referred to as ‘ART-eligible’), were receiv-
ing treatment [18]. With the gaps in linkage to care, es-
pecially prior to ART initiation [18,20,21], it remains
important to continue evaluating the effect of PITC on
HIV follow-up care with different patient groups, espe-
cially in high HIV prevalence and low-resource settings
such as South Africa. Moreover, given the strong associ-
ation between sexually transmitted infection (STI) and the
risk of acquiring and transmitting HIV [22,23], HIV pre-
vention, HIV detection and linkage to HIV care amongst
STI patients are of particular importance; and there is a
gap in evidence on the effect of expanding HIV testing
strategies, such as PITC on linkage to care for this patient
group.
Clinical guidelines for linkage to care in South Africa
required CD4 testing and clinical examination for all
newly diagnosed HIV-positive patients as soon as pos-
sible, usually within a week of testing. At the time of the
study, patients not yet eligible for ART (CD4 > 200 cells/
mm3 and no clinical symptoms of AIDS) would be ad-
vised to attend every 6 months for a clinical assessment
and CD4 count monitoring. If ART-eligible (CD4 ≤ 200
cells/mm3 and/or HIV clinical stage IV) patients would
be referred for ART initiation. For patients referred for
ART initiation, clinical guidelines required baseline viral
load testing at the point of starting ART. (During the
course of this study, this requirement was changed to
viral load testing within 6–9 months of starting ART).
Retention in care for ART was monitored by regular
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linkage to care refers to whether a patient accessed a
CD4 test after testing HIV positive and whether they
accessed a viral load test if they were eligible to be initi-
ated on ART during the observation period. Access to
viral load testing was used as a proxy for having been
linked to ART.
The main non-randomised controlled trial, of which
this study is nested within, found that participants in the
PITC arm in public STI services in Cape Town, were
more likely to accept HIV testing compared with those
in the VCT arm [24]. The aim of this nested follow-up
study was to compare linkage to care (as measured by
CD4 and viral load testing) of STI patients diagnosed
HIV-positive in clinics with PITC versus those diagnosed
HIV-positive in clinics with the standard VCT approach.
Secondary indicators were HIV immune status (CD4
count) and time taken to linkage to care.
Methods
Study setting
The study was performed in the publicly funded primary
healthcare (PHC) services in Cape Town, South Africa.
Although the Western Cape Province and Cape Town
have amongst the lowest HIV prevalence in the country
the prevalence varies dramatically between sub-districts
within the city. For instance, in 2005, the HIV preva-
lence for pregnant women was estimated at 15.7% for
Cape Town, whilst on a sub-district level the figures
ranged from as low as 5.1% to as high as 32.6% [25]. The
sub-districts with the highest figures also tended to be
those with the poorest socio-economic profile.
Study design
This nested cohort study was conducted in the context
of a controlled trial (ISRCTN 93692532) that evaluated
whether PITC increased HIV testing rates in 7 interven-
tion and 14 control primary health care (PHC) clinics in
Cape Town. Details of the trial study design, setting, the
PITC intervention and results were described elsewhere
[24]. This follow-up study reviewed retrospective labora-
tory records of CD4 and viral load tests of the 930 pa-
tients who were diagnosed HIV-positive during the
period of the controlled trial between January 2007 and
June 2007. Laboratory records of CD4 and viral load
testing were used as indicators of linkage to care because
these tests can only be requested by a nurse or doctor.
Access to these tests was used as a proxy for whether
patients received the appropriate type of care, though it
is acknowledged that this is not a comprehensive indica-
tor of linkage to care. The existence of a laboratory test
record does not indicate that the patient returned and
was informed of the test result and this is noted as a
limitation in the Discussion section.The main controlled trial was done in an operational
setting which precluded randomisation of sites. In the
main trial, the intervention and control clinics were com-
pared at baseline on multiple demographic and service de-
livery factors (data not shown- see Additional file 1).
The primary outcomes were i) the proportion of HIV-
positive patients who had had a CD4 test record and ii)
of those with a CD4 test record, the proportion of ART-
eligible patients with a viral load test record. Secondary
outcomes were HIV immune status (as reflected by their
CD4 count) and the time taken between HIV testing and
CD4 testing and between CD4 testing and viral load
testing. The study hypothesised that the PITC interven-
tion would offer more opportunity for linkage to care
compared to the VCT option (due to the closer, routine
involvement of clinical staff in the HIV testing process).
The PITC intervention and HIV linkage to care
STI services and HIV testing is available to all patients in
PHC clinics, free of charge. HIV testing is usually provided
by trained HIV lay counsellors via the VCT approach
which require patients to self-initiate or be medically re-
ferred for HIV pre- and post-test counselling. In clinics
with the PITC intervention, the STI nurses offered HIV
testing routinely as part of their STI consultation, through
a series of brief steps aimed at assessing test readiness,
getting consent and performing the rapid test. After
performing the HIV test, the nurse linked the patient
with the HIV lay counsellor for the test result and post-
test counselling.
The differences and similarities between the standard
VCT approach and the adapted version of the PITC ap-
proach used in this study, is outlined in Table 1. In both
intervention and control sites, the reason for the clinic
visit is to seek treatment for STI. The difference in the
PITC sites was that all STI patients would routinely be
offered an HIV test as part of the STI consultation,
whereas in the control sites, patients would not auto-
matically be offered HIV testing in STI consultation. In
the control sites, there was no standardised requirement
for the clinician to raise the issue of HIV testing in the
STI consultation, and in most cases, patients in control
sites would only be referred to the HIV testing and
counselling services, based on medical reasons (medical
referral), such as the presence of HIV-related symptoms.
Such patients would usually make a separate appoint-
ment for HIV testing and counselling with lay health
counsellors, or they may choose to ignore the medical
referral.
In both testing approaches there were no explicit steps
outlined for ensuring effective linking of HIV positive
patients to follow-up care, other than what the general
clinical guidelines recommended. When patients tested
HIV positive, they were given emotional support and
Table 1 Similarities and differences between the VCT and the PITC interventions for patients seeking STI care in Cape
Town
Voluntary counselling and testing for HIV for STI patients in
control sites
Provider–initiated HIV testing and counselling for STI
patients in intervention sites
Patient access • Patients come to the clinic to seek care for an STI complaint. • Patients come to the clinic to seek care for an STI
complaint.
• HIV testing is not offered by the STI nurse as part of the
standard clinical care.
• The STI nurse routinely offers all STI patients an HIV test as
part of the standard STI clinical care.
• The STI nurse may refer some STI patients for HIV testing,
usually for medical reasons.
• The STI patient is asked to opt-out of HIV testing during
the STI consultation.
• Should patient choose to adhere to the medical referral, then
a separate clinic visit is usually required for the HIV counselling
and testing to be done.
Providers • Usually provided by trained lay counsellors. • Professional healthcare providers (STI nurses) trained to
provide PITC.
• Basic counselling training can be lengthy (10 to 20 days). • Training is short (2 days) and is focused on how to offer
the test and how to get informed consent from patients.
Primary purpose
of the intervention
• The primary purpose is to promote uptake of HIV testing and
to link people to HIV care and prevention services.
• The primary purpose is, similarly, to promote uptake of HIV
testing and increase the number of people who know
their HIV status.
• The emphasis is on assessing patient readiness to test, and the
counsellor is supposed to remain neutral about the choice
(and not to promote taking the HIV test as the preferred
option).
• The intervention also aims to integrate HIV testing
efficiently into a regular STI consultation, while still
respecting the need for patient informed consent.
• The provider can promote HIV testing as the medically
recommended option (rather than remaining neutral about
the preferred choice).
Pre-test encounter • Patient-centred counselling techniques focus on promoting an
informed decision and include basic HIV information, risk
assessment, an assessment of readiness to test, and risk
reduction messages.
• Offer of HIV testing is introduced using regular clinical
communication as part of the STI consultation. This
involves a brief explanation of why an HIV test is
recommended in the context of an STI consultation, a brief
assessment of the patient’s readiness to test for HIV,
offering the HIV test and opportunity for the patient to ask
questions. Risk assessment and risk reduction are dealt
with as part of the regular STI consultation.
• Written informed consent for testing is obtained. • Written informed consent for testing is obtained.
• Can take up to 25 minutes. • Intervention is meant to add maximum 5 to 10 minutes to
the STI consultation when efficiently integrated.
The HIV test • Due to limits to their scope of practice, lay counsellors cannot
perform the rapid HIV tests themselves.
• The nurse does the HIV rapid test along with other blood
tests during the STI consultation, which reduces waiting
time for patients.




• The nurse communicates the result of the rapid HIV test to the
lay counsellor.
• The nurse refers the patient to a lay counsellor in the
facility, to receive the HIV test result and post-test
counselling.
• The lay counsellor then informs the patient and provides post-
test counselling.
• The patient may need to wait for a lay counsellor to be
available.
• The primary focus is on providing emotional support for HIV-
positive patients and linking them to care, as well as providing
risk reduction messages for HIV-positive and HIV-negative
patients.
• The primary focus is similarly on emotional support for
HIV-positive patients, but with stronger linkage to HIV care
(e.g., the nurse does the CD4 blood test on the same day,
and the patient is encouraged to attend follow-up sessions
with the lay counsellor).
• Lay counsellors are encouraged to provide up to three follow-
up counselling sessions with HIV-positive patients.
• There is less focus on HIV-negative patients.
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examination. At the time, there was no standard proto-
col recommending CD4 testing on the same day. For the
PITC approach, STI nurses offered HIV testing in theSTI consultation and it was thought that this would be
more advantageous for linking patients to care. For in-
stance, the clinical consult allowed nurses to more easily
request a CD4 test blood test on the same day and to
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ceive their CD4 test result together with their other STI
test results.
Study population and sampling
The main controlled trial study was adequately powered
to detect the hypothesised differences between HIV test
uptake across arms, as described elsewhere [24]. The
sample size for this nested follow-up study, however,
was determined by the number of patients who tested
HIV-positive in the controlled trial. As the sample size
was pre-determined and we did not have any data to in-
form an estimation of an effect size, we did not perform
a sample size calculation for this nested study. This is
discussed as a limitation.
Data collection
We started with a clinic-based HIV testing register with
clinical and demographic data on all 930 patients who
tested positive for HIV in the controlled trial between
January and June 2007. In order to assess the linkage to
care outcomes for these individuals, we then needed to
match them to CD4 and viral load test records that are
held in the National Health Laboratory System’s (NHLS)
central database.
The first stage of the data collection process was to
search for records of CD4 testing during a 12-month ob-
servation period from January to December 2007. We did
not standardise the follow-up period due to logistical chal-
lenges. Data on CD4 lab records was not yet available be-
yond December 2007 to allow for standardised one year
follow-up period for each patient (which would have re-
quired data to be available up to June 2008). We wanted
to allow for the maximum follow-up period, rather than
shortening the observation period to a standard 6 months.
In effect, the observation period was between minimum
6 months and maximum of 12 months.
To match names with records, we searched the NHLS
database using a range of patient identifiers, including
name and surname, gender, and age as well as the pa-
tient’s clinic folder number. This process was necessary
since clinic and laboratory records did not use unique
patient identifiers (such as the unique South African citi-
zen identity number or ID). We used an algorithm for
the electronic search using multiple variables and pos-
sible variations of these variables (such as transposed pa-
tient name and surname). The algorithm also made use
of a ‘sounds-like’ function to look for additional matches
on names.
The results of the electronic matching process were
then reviewed manually by one author (NL), duplicates
and non-matches were removed, and a final set of true
matches was identified, using the same range of variables
mentioned above. The electronic and manual searcheswere done blind to trial allocation status. Quality control
of the matching process was done in two steps. First we
took a randomly selected sample of those HIV positive
names for which no matching CD4 record could be found
and we repeated the electronic search to determine if the
initial search may have missed possible matches for CD4
records. Of the 20 randomly selected names, the second
electronic search located a CD4 record for 1 name on the
testing register. Given the time consuming process it re-
quired to perform the detailed individual search for
matches for each of these 20 records, it was decided not
to repeat the search for the full sample of patients with
missing records. The outcome of this quality check (where
1 out of a sample of 20 was found to have been missed by
the initial electronic search) was considered a reasonable
underestimation (5%) by this search method, given the
challenge presented by the absence of a unique patient
identifier. The second step in the quality check related to
the manual search and inclusion process and was aimed at
ensuring the accuracy of the matching process for CD4 re-
cords. This involved an independent check of the manual
record matches (by a senior colleague and co-author AB)
of the accuracy of a random sample of 20 matched re-
cords. This independent quality check did not identify any
discrepancies that could affect the main outcomes [26].
The second stage of the data collection process, done
one year later, searched for viral load test records for
the 622 HIV-positive patients who were identified in the
first stage described above as having a CD4 test record.
The same NHLS database was searched, this time for a
24-month observation period from January 2007 and
December 2008. The observation periods were not the
same for each patient, for similar reasons as described
above for the CD4 testing record search. The minimum
potential follow-up time therefore was 18 months and
the maximum was 24 months. The search process was
simplified using Link Plus software, a probabilistic rec-
ord linkage programme initially designed by Centers for
Disease Control and Prevention (CDC) (www.cdc.gov/
cancer/npcr/tools/registryplus/lp.htm).
A proportion of patients (62 or 10%) who had CD4
test records after HIV testing, also had a record of CD4
testing before their HIV test date. The most likely ex-
planation for this is that these patients knew their status
to be HIV-positive and had previously undergone CD4
testing, but nevertheless re-tested for HIV during the
intervention period. Such ‘known positive’ patients were
excluded from the analysis of the proportion with viral
load testing and from calculations of timing of CD4 and
viral load testing. This is because there was a chance
that their previous CD4 testing in another (or the same)
service, may have been followed by a request for viral
load testing to be done. The appearance of a record of
viral load testing for these individuals after HIV testing
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cannot automatically be ascribed to this intervention.
Data analysis
Data analysis was performed using STATA statistical soft-
ware, Version 10. Analysis compared the study arms with
respect to the proportion of HIV-positive patients with
CD4 records, their CD4 levels, and the proportion of ART-
eligible patients with viral load records, as well as the tim-
ing of CD4 and viral load testing. Analysis used generalised
linear models and took clustering by clinic into account
using variance estimators in STATA which produced a
robust Standard Error. Logistic regression was performed
to analyse the difference between arms with respect to
the primary and secondary outcomes. The Rank Sum and
Weighted T-test was used for the cluster-level analysis.
Kruskal-Wallis, a non-parametric, one-way analysis of vari-
ance test, was used to test for the equality of population
median CD4 values. Kaplan-Meier estimates and Cox pro-
portional hazards regressions were used for the time-to-
event analysis of CD4 and viral load testing for those with
observed events.
Ethics
Ethical approval was obtained from the University of Cape
Town Research Ethics Committee (HREC, REC#295/
2007) and both the Cape Town and Western Cape Provin-
cial health authorities gave permission for the evaluation.
Results
Participants
As reported elsewhere, the main outcome of the con-
trolled trial was that the proportion of STI patients that
tested for HIV was significantly higher in intervention
than in the control arm (intervention = 1725 or 56.4%
and control = 2821 or 42.6%, p = 0.037) [24]. As shown
in Table 2, the proportion of patients who tested HIV-
positive between study arms was comparable (326 or
18.6% in the intervention clinics and 604 or 21.4% in the
control sites, p = 0.147), as was the median age (28 years
in intervention and 26 years in control clinics). In both
study arms, the majority (approximately two thirds) of
the patients were female. The majority of females (91%)
were 35 years or younger and the majority of males
(83%) were 25 years and older.Table 2 Participants: proportion tested HIV positive and dem
Study participants Interventio
1. STI patients tested for HIV 56.4 (1752)
2. Tested HIV-positive (as % of all tested) 18.6 (326)
3. Median age, years (range) 28 (14–54)
4. Gender: women 62.9 (205)
*Significant difference at p < .05. Pearson chi2,.The baseline comparison of sites in the main trial
found no significant differences, except for one vari-
able; the HIV acceptance rates of VCT patients (see
Additional file 1). When adjusting for this difference in
baseline characteristics, it did not change the interpret-
ation of the findings in the main trial, as reported else-
where [24].
CD4 testing and viral load testing
The total number of potentially matching CD4 test re-
cords generated was 3 679 records. The manual search
for matched CD4 records resulted in a final list of 824
true matches (narrowed down from the initial 3 679 po-
tential matches). Some patients were found to have more
than one CD4 test done. The first test record after HIV
testing was included in the analysis and further CD4 re-
cords were removed from the dataset. After removal of
these multiple CD4 records as well as erroneously dupli-
cated records, the final sample of true matches for CD4
records was 622 HIV positive patients. The proportions
of ‘known positives’ (those with CD4 test dates preced-
ing their HIV test date in this study) were similar be-
tween arms with 11.4% (26 patients) in the intervention
arm and 9.1% (36 patients) in the control arm (p = 0.363,
Pearson chi2). As mentioned earlier, these ‘known posi-
tives’ were excluded from further analysis for viral load
access and for the timing of access to CD4 and viral load
testing.
Table 3 details the main outcomes on linkage to care
for those who tested HIV-positive. In the pooled analysis
of both arms, the proportion with a record of a CD4
testing was 66.9% or 622 of the 930 HIV-positive pa-
tients. Clinics with the PITC intervention did not have a
higher proportion of patients with CD4 test records
69.9% or 228 patients in the intervention and 65.2% or
394 patients in the control sites, with an odds ratio of
0.82 (CI: 0.44-1.51; p = 0.526).
Among the patients with CD4 test records, less than
one quarter of patients were ART-eligible (according to
CD4 level ≤200 cells/mm3), with 19% in the intervention
and 21% in the control group being ART-eligible. When
considering records of viral load testing for only the
ART-eligible category (CD4 ≤ 200 cells/mm3), there was
an absolute difference of 12.2% between arms in the pro-
portion of patients who had a record of viral load testographic information





Table 3 Linkage to care: CD4 and viral load testing done, median CD4 values and median time taken, by study arm
Participants Intervention Control Odds ratio P value
CD4 test done (as % all HIV-positive) 69.9% (n = 228/326) 65.2% (n = 394/604) Adjusted 0.82 (CI: 0.44-1.51) 0.526
Unadjusted 0.81 (CI: 0.43-1.52) 0.504
Viral load test done (as % of CD4 done) 14.9% (n = 30/202) 10.9% (n = 39/358) Adjusted 0.69 (CI: 0.42-1.12) 0.131
Unadjusted 0.70 (CI: 0.48-1.02) 0.064
Median CD4 (cells/mm3) (Range) 386 (17–1509) 364 (11–1445) 0.446
Median time (days) from HIV testing to CD4 testing (IQ range) 3 (1–290) 2 (1–337) 0.646
Median time (days) from CD4 to viral load testing for all
CD4 categories (IQ range)
245 (177–560) 306 (195–550) 0.622
Median time (days) from CD4 to viral load testing for
ART- eligible patients (CD4 ≤ 200 cells/mm3) (IQ range)
214 (177–230) 288 (195–492) 0.007*
*Significant difference at p < .05. Pearson chi2, Log rank test.
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sub-groups (19 out of 39 or 33.3% intervention arm ver-
sus 16 out of 76 or 21.1% control arm). The numbers in
these three CD4 sub-groups were, however, too small to
test statistically for differences between arms.
In the pooled analysis (intervention and control
groups), the proportion with viral load test records was
12.3% (irrespective of their CD4 counts and whether
the test result was received). In the intervention arm
the proportion was higher, but this difference was not
found to be statistically significant (14.9% intervention
versus 10.9% in the control arm); OR 0.69 (CI: 0.42-
1.12; p = 0.131). Two tests were used in the cluster-
level analysis and the p-values for the cluster-level
analysis were not different from the p-values in the indi-
vidual analysis (for CD4 test done, Rank sum p = 0.332
and Weighted t-test p = 0. 447 and for viral load test done
Rank sum p = 0.101 and Weighted t-test p = 0.153).
HIV immune status
The median CD4 levels of patients in both arms were
similar (intervention = 386 cells/mm3, IQ range 17–1509
and control = 364 cells/mm3, IQ range 11–1445; p = 0.446,
chi2 = 0.581). The study compared the proportions of pa-
tients with CD4 values in three categories from lowest to
highest (≤200, 201–350 and >350 cells/mm3) and found
no association between study arm and these CD4 categor-
ies. Using the highest CD4 category as a reference, there
was no significant difference between arms for the lowest
CD4 category (≤200 cells/mm3, p = 0.578) and for the
middle CD4 category (201–350 cells/mm3, p = 0.672).
Gaps in linkage to care
In Figure 1, the main outcomes are presented as a cascade
of care in both arms of the study. It shows the gap in link-
age to CD4 testing and the gap in linkage to viral load test-
ing for those who were ART-eligible (the latter being a
proxy for the gap in linkage to ART). For those patients
diagnosed HIV-positive, 30.1% in the intervention and34.8% in the control arm, did not have a record of CD4
testing done - representing the first gap in linkage to care
in the graph. The proportions of patients who were ART-
eligible (shown in the smaller green bars), were 19% in the
intervention group and 21% in the control group–this was
illustrated as a proportion of those with CD4 test re-
cords (the second, maroon set of bars). The majority of
ART-eligible patients did not have a record of a viral load
test (66.7% for the intervention arm and 78.9% for the
control arm) and this represents the second and larger gap
in linkage to care.Time to accessing CD4 testing and viral load testing
The median time from HIV testing to accessing CD4 test-
ing and from CD4 testing to viral load testing was similar
across both arms, except for one sub-group (Table 3, final
row). For the sub-group of ART-eligible patients, there
was a significant difference between arms in time between
their date of CD4 measurement and their date of viral load
measurement (214 days in intervention vs. 288 days in
control arm, HR: 0.417, 95% CI: 0.221-0.784, p = 0.007),
indicating that those in the PITC intervention accessed
viral load testing sooner.Discussion
The study found that in both arms, the majority (more
than two thirds) of patients had a CD4 tests done. The
PITC intervention did not improve the proportion of
HIV positive patients with CD4 tests done, nor did it fa-
cilitate quicker access to CD4 testing. Most CD4 tests in
both arms were done within less than a week of HIV
testing and this, together with the relatively high level of
CD4 tests done, point to a strength of the health service
in terms of ensuring that appropriate blood tests are
done as the first stage in linkage to care. However, this
indicator cannot tell us what proportion of those with
CD4 test records actually returned to the clinic and was
informed of the test result.
Figure 1 Gaps in linkage to care: proportion of HIV-positive patients with no record of CD4 testing and the proportion of ART-eligible
patients with no record of viral load testing, by study arm. Figure 1 shows the main outcomes as a cascade of care to illustrate the gaps in
linkage to care after testing HIV-positive in both arms of the study. The first gap in linkage to care was those HIV-positive patients who did not
have a record of CD4 testing (indicated by the top set of brackets). The proportion of those patients with CD4 test records is represented by the
second set of maroon-coloured bars. The third set of smaller green bars is the proportion of those with CD4 records who were ART-eligible.
The last set of small, purple bars indicate those ART-eligible patients with records of viral load tests (expressed as a proportion of those who
were ART-eligible). Finally, the second gap in linkage to care in the graph is the proportion of ART-eligible patients with no record of viral load
testing (shown by the lower set of brackets).
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tests done (as a proportion of all those with CD4 tests
done). Not all those with CD4 tests would have been eli-
gible for initiation onto ART, so this indicator cannot
strictly be taken as a measure of linkage to care in this
study. The finding indicates that patients with higher
CD4 counts are also accessing viral load tests (perhaps
based on their clinical symptoms) and that even so, the
proportions with access remained low. Due to small
numbers, the study was not able to accurately detect dif-
ferences between arms in proportions of ART-eligible
patients with viral load tests.
The study did find that the time from CD4 testing to
viral load testing for ART-eligible patients was approxi-
mately 2.5 months (74 days) shorter in the intervention
arm as opposed to control arm. If viral load testing is
used as a proxy for ART, then this indicates that ART-
eligible patients may have been initiated onto ART more
quickly in the clinics with the PITC intervention arm as
compared to patients in clinics with the VCT approach
to HIV testing. Given the small numbers observed, this
finding needs to be confirmed by larger studies. The
finding points to the potential benefit of the PITC inter-
vention for those most in need of HIV follow-up care.
The study was not able to investigate the possible rea-
sons for this quicker access to viral load testing in the
PITC intervention arm. One suggestion is that the closer
involvement of nurses with the process of HIV testing
within the clinical STI consultation, may have allowed
nurses to more easily inform patients of the medical
benefits of seeking immediate referral for ART initiation.Also, all STI patients are asked to return for a follow-up
visit to receive their syphilis test result, so this could
have provided patients with a ready-made opportunity
to return to receive their CD4 test result and for timely
referral for ART initiation.
The implication of removing the 10% ‘known positive’
patients from the analysis of viral load access and timing
of CD4 and viral load testing is unclear. On the one
hand, previous HIV testing and CD4 testing may imply
greater contact with the health service and therefore in-
creased chances for linkage to further care (e.g. viral load
testing and ART initiation). On the other hand, the pres-
ence of multiple, parallel testing experiences may reflect
on patient health seeking behaviour that might be limit-
ing further linkage to care.
For the sample as a whole (across both arms), a higher
proportion of patients who were ART-eligible (in the
category CD4 ≤ 200 cells/mm3) had viral load tests done
compared to those in higher CD4 categories. This could
be taken as an indication that irrespective of the ap-
proach to HIV testing, those HIV-positive patients most
in need of linkage to care were in fact prioritised by
health providers for ART initiation, which is reassuring.
The HIV immune status was similar across arms and in
line with median CD4 levels reported in other LMIC
and high-income countries [27-29] and this is perhaps
indicative of the high risk status of STI patients in this
setting [21,30,31].
The study identified gaps in linkage to care irrespect-
ive of the HIV testing approach used. Roughly one third
of HIV-positive patients did not have a record of a CD4
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ART-eligible patients did not have a viral load test rec-
ord, indicating that they may not have been initiated
onto ART. This is in line with other studies pointing to
a loss of linkage to care after HIV testing and prior to
initiation of ART in South Africa and the sub-Saharan
region [18-20]. A systematic review of linkage to care
between testing and treatment in sub-Saharan Africa
concluded that: “Studies of retention in pre-ART care
report substantial loss of patients at every step, starting
with patients who do not return for their initial CD4
count results and ending with those who do not initiate
ART despite eligibility” [18].
Critics of expanded testing strategies such as PITC
have expressed concern that whilst it may increase test
uptake, it may also increase the number of HIV positive
patients who are not effectively linked to care, especially
in high prevalence and under-resourced settings such as
South Africa. In this study, HIV positive STI patients in
both arms had similar levels of linkage to care and simi-
lar gaps in linkage to care (except for the timing to viral
load testing). One interpretation is that, at minimum,
the PITC intervention did not disadvantage patients with
respect to linkage to care and that it may hold opportun-
ities for more timely linkage to care.
Nevertheless, the low levels of linkage to viral load
testing for ART-eligible patients point to an extreme fail-
ure of the health system. If the push for scale-up of
PITC is to reduce missed opportunities for diagnosis
and linkage to care, then the still high loss to follow-up
despite PITC is a major short coming of the initiative. A
process evaluation of the main controlled trial on im-
proving HIV test uptake, indicated that within a busy
primary health care setting nurses were struggling to ef-
ficiently integrate HIV testing into the STI consultation,
and that this may be the part of the reason for the
smaller than anticipated effect size in HIV test uptake
[32]. Similar limits on nurse time and challenges with ef-
ficient patient flow, may also account for the low linkage
to care found in the PITC arm. Also, in this PITC inter-
vention, nurses were referring their STI patients to the lay
counsellor to receive the test result and post-test counsel-
ling (a mechanism introduced to save nurse time) and this
break in continuity of care could have created missed op-
portunities for linking patients to care.
It could be argued that, even at the low levels of linkage
to care found in this study, there may still be benefits
arising from routinising HIV screening in this setting.
Modelling of the effectiveness of routine annual HIV
screening in South Africa concluded that it offered med-
ical, prevention and cost-effectiveness benefits, even in
highly constrained service delivery settings where the test
acceptance rate and linkage to care rate could be as low as
20% [33]. Even so, efforts to improve linkage to care willbecome more critical given the increased demand on the
health services from the change in ART-eligibility criteria
(CD4 ≤ 350), and the increased numbers of people who
have been testing since the introduction of the National
Department of Health’s National HIV campaign that
started in 2010 [34].
Linkage to and retention in HIV care has many complex
components related to both patient and health systems
factors - and the HIV testing approach is but one element
of a set of moving parts that make up the health system
delivering HIV linkage to care. New interventions such as
PITC may be constrained by broader organisational bar-
riers such as poor patient flow, poor monitoring and
evaluation of patients and the absence of mechanisms for
recalling HIV positive patients to ensure follow-up visits
take place. This study did not investigate these and other
components identified as requirements for successful link-
age to care - such as for instance, strengthening service
delivery and management capacity [18,20,35,36].
New strategies to expand HIV testing approaches (as
well as standard VCT approaches) could do more to in-
clude explicit steps aimed at increasing HIV prevention
and linkage to care. When up-scaling PITC for STI pa-
tients (and for all patients in medical settings), the de-
sign of the intervention should allow for easy integration
with the clinical consultation, without fragmenting the
clinical tasks and the tasks related to HIV testing and
linkage to care [32]. Also, it should be standard proced-
ure for nurses and lay counsellors to request a CD4 test
on the day of HIV testing and there should be a recall
mechanism for patients who are ART-eligible based on
their low CD4 count. Other factors found to promote
linkage to care and that should be further investigated
also for PITC interventions, include same day point-of-
care CD4 testing, improved patient tracing and persistent
reminders of follow-up visits, educational programmes to
enhance staff friendliness and reducing the cost of acces-
sing care [7,18,20,35,37].
The results of this study are likely to apply to sub-
Saharan Africa, where health systems constraints may be
prominent in limiting the potential impact of new inter-
ventions for expanding HIV testing and increasing link-
age to care.
Strengths and limitations of this study
The study has significant strengths and limitations. The
strengths include the use of laboratory records which are a
good proxy for follow-up care as they represent a centra-
lised and comprehensive source of information about CD4
and viral load testing across all primary health facilities. It
is also a more efficient and accurate way of extracting data
on these follow-up clinical tests, rather than, for instance,
reviewing individual patient folders that may be incomplete
and harder to access. Another strength is that the
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limited to Cape Town, which increased the chances of de-
tecting follow-up at clinics other than where the patient
tested. The study also allowed for a reasonably long time-
frame for follow-up periods, from a minimum of 6 months
for CD4 testing and a minimum of 18 months for viral load
testing.
A major limitation of the study was that the interven-
tion and control sites were not randomly allocated which
introduced the risk of bias. Baseline comparison of inter-
vention and control sites for the main trial aimed to
limit this bias to some extent. As reported earlier, none
of the baseline variables were found to be significantly
different, except one on ‘HIV test acceptance’ rates (see
Additional file 1). We did not consider this a major risk
for confounding because this variable referred to a dif-
ferent patient population (all clinic patients) and a differ-
ent set of health providers (lay counsellors). In addition,
while the difference in this VCT acceptance rate between
the two arms was statistically significant, the rate itself
was very high in both arms (93% and 85%), indicating a
relatively high level of functioning in both arms [24].
The main controlled trial was not designed to measure
access to care as a primary outcome and so the sample
sizes did not allow for robust statistical analysis; the study
was underpowered to detect smaller differences between
the arms. Another limitation is the risk of underestimation
of linkage to care when using laboratory records only;
some patients may have started ART without a baseline
viral load test being done. As mentioned earlier, during
the course of this study, the health services removed the
requirement for a baseline viral load test to be done at
ART-initiation and this further complicates the interpret-
ation of the findings on viral load testing.
Ideally, the data should have been double-extracted and
double-entered for accuracy, which was not done. The ab-
sence of unique patient identifiers complicated the search
for CD4 test records and may have resulted in underesti-
mation of CD4 records. As described in the Methods sec-
tion, we aimed to improve the accuracy of electronic and
manual data extraction process. Searching only the NHSL
database for the Western Cape Province only means that
it would have missed patients who may have migrated to
other provinces, especially to the neighbouring Eastern
Cape Province. The effect of this on the results is likely to
be small as migrations to the Eastern Cape are usually
temporary transitions with patients tending to return to
the Western Cape Province to seek out what is considered
better medical care. The search for viral load testing was
limited to only those who had CD4 test records and this
would missed those patients who initiated ART without
having a CD4 test done, based on their clinical symptoms
only. This number is likely to be low for STI patients com-
pared to other patient groups, like TB patients, where co-morbidity is likely to be accompanied by more serious and
acute symptoms of illness. Although the study allowed for
a reasonably long timeframe for follow-up periods, this
may still be a limited time interval (as viral load testing
may only have been done 9 months after a patient was ini-
tiated on ART). Nevertheless, the study design would have
been strengthened if the follow-up period was standar-
dised for all patients, even if this meant a shortened
follow-observation period. The study also did not allow
for assessing linkage to care for those not yet eligible for
care or the rate of retention in care for ART patients. The
effect of mortality on the study outcomes could not be de-
termined as mortality is not tracked in routine health data
or in laboratory records and some HIV positive patients
with no follow-up data, may have died.
Further studies should consider both standardising
and extending the follow-up period and should include
investigation of follow up care for pre-ART patients (for
example, monitoring 6 monthly follow-up CD4 testing
for pre-ART patients). The introduction of the patients’
identity number (as a unique patient identifier) in rou-
tine records and/or for research purposes, could help to
track mortality, as was done in a more recent trial on
nurse-initiated ART [38].
Finally, the study was not able to ascertain what pro-
portion of patients with a CD4 record actually returned
to the clinic to get their CD4 test result, nor was it able
to examine the reasons for the gaps in linkage to care,
or to assess quality of care received. Larger studies using
a longitudinal study design that can track patient care
prospectively and/or retrospectively, as well as using
multiple sources of data on care seeking (such as the
newly introduced electronic patient record system for
ART, in combination with laboratory data) could address
some of the limitations identified in this study.
Conclusion
Strategies for expanding HIV testing through routine
HIV screening in medical settings should be evaluated
for its effect on linkage to care after testing HIV positive
as this can contribute to improved morbidity and mor-
tality as well as reduced transmission of HIV. This study
investigated linkage to care of STI patients following the
introduction of PITC as compared to VCT for STI pa-
tients, and found no difference in the main outcomes of
patients linked to CD4 testing and viral load testing.
Numbers were too small to detect a difference in access
to viral load testing for ART-eligible patients. In terms
of secondary outcomes, ART-eligible patients had
quicker access to viral load testing in the intervention
arm – a finding that points to the potential benefit of
having nurse clinicians offer HIV testing within a clinical
consultation. This needs to be confirmed in larger stud-
ies. The study found major gaps linkage to care across
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majority were not linked to viral load testing and may
therefore not have been initiated on ART, even though
such a low CD4 count would have required urgent med-
ical intervention. HIV testing strategies alone cannot ad-
dress these gaps in linkage to care, (as this requires a
range of health systems solutions), but it can do more to
include explicit measures aimed at ensuring patients are
linked to care shortly after testing HIV positive.Additional file
Additional file 1: Table S1. Baseline comparison of intervention and
control clinic demographics and service profile. Annual data for 2005.
The table provides comparative baseline on a range of demographic
and service outcome variables to investigate differences and similarities
between the clinics in the intervention and control sites for the
controlled trial that measured HIV test uptake [24]. The variables
compared are total and STI caseload and performance outcome for the
HIV testing services and the TB treatment services. There was no
statistical differences between the two sites, except for one variable,
that of ‘HIV test acceptance’ rate.
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